Brief: USANA Health Sciences Reports First Quarter Net Sales Of $248 Mln And Diluted EPS Of $0.95
April 25 (Reuters) - USANA Health Sciences Inc USNA.N :
* USANA HEALTH SCIENCES REPORTS FIRST QUARTER NET SALES OF
$248
MILLION AND DILUTED EPS OF $0.95
* USANA HEALTH SCIENCES INC - SEES 2023 CONSOLIDATED NET
SALES
$875 - $950 MILLION; SEES 2023 DILUTED EPS $2.40 - $3.30
Source text for Eikon: ID:nBw4crRpTa
Further company coverage: USNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on USANA Health Sciences
See all newsBrief: Usana Schedules Third Quarter 2026 Earnings Release And Conference Call
Brief: Usana Health Sciences - Enters First Amendment To Credit Agreement On Sept 30, 2026 - SEC Filing
USANA Health Sciences Q2 sales fall amid weaker Hiya and Rise performance
Brief: USANA Health Sciences Q2 EPS USD -1.16
Usana Health Sciences Inc Expected To Post Earnings Of 43 Cents A Share: Earnings Preview